Sexually transmitted infections: Vaccine develoment for global healthBROUTET, Nathalie; DEAL, Carolyn D; FRUTH, Uli et al.Vaccine. 2014, Vol 32, Num 14, issn 0264-410X, 121 p.Serial Issue

Towards a safe and effective chlamydial vaccine: Lessons from the eyeMABEY, David C. W; HU, Victor; BAILEY, Robin L et al.Vaccine. 2014, Vol 32, Num 14, pp 1572-1578, issn 0264-410X, 7 p.Article

Vaccines to promote and protect sexual health: Policy challenges and opportunitiesHAWKES, Sarah; KISMÖDI, Eszter; LARSON, Heidi et al.Vaccine. 2014, Vol 32, Num 14, pp 1610-1615, issn 0264-410X, 6 p.Article

Current status of syphilis vaccine development: Need, challenges, prospectsCAMERON, Caroline E; LUKEHART, Sheila A.Vaccine. 2014, Vol 32, Num 14, pp 1602-1609, issn 0264-410X, 8 p.Article

Vaccines against sexually transmitted infections: The way forwardBROUTET, Nathalie; FRUTH, Uli; DEAL, Carolyn et al.Vaccine. 2014, Vol 32, Num 14, pp 1630-1637, issn 0264-410X, 8 p.Article

Vaccines against gonorrhea: Current status and future challengesJERSE, Ann E; BASH, Margaret C; RUSSELL, Michael W et al.Vaccine. 2014, Vol 32, Num 14, pp 1579-1587, issn 0264-410X, 9 p.Article

Vaccines for sexually transmitted infections: Past, present and futureFRUTH, Uli; BROUTET, Nathalie; DEAL, Carolyn et al.Vaccine. 2014, Vol 32, Num 14, pp 1525-1526, issn 0264-410X, 2 p.Article

Current status and prospects for development of an HSV vaccineJOHNSTON, Christine; KOELLE, David M; WALD, Anna et al.Vaccine. 2014, Vol 32, Num 14, pp 1553-1560, issn 0264-410X, 8 p.Article

HPV vaccines to prevent cervical cancer and genital warts: an updateDOCHEZ, Carine; BOGERS, Johannes J; VERHELST, Rita et al.Vaccine. 2014, Vol 32, Num 14, pp 1595-1601, issn 0264-410X, 7 p.Article

Health care professional communication about STI vaccines with adolescents and parentsHOFSTETTER, Annika M; ROSENTHAL, Susan L.Vaccine. 2014, Vol 32, Num 14, pp 1616-1623, issn 0264-410X, 8 p.Article

Development status and future prospects for a vaccine against Chlamydia trachomatis infectionHAFNER, Louise M; WILSON, David P; TIMMS, Peter et al.Vaccine. 2014, Vol 32, Num 14, pp 1563-1571, issn 0264-410X, 9 p.Article

Toward global prevention of sexually transmitted infections (STIs): The need for STI vaccinesGOTTLIEB, Sami L; LOW, Nicola; NEWMAN, Lori M et al.Vaccine. 2014, Vol 32, Num 14, pp 1527-1535, issn 0264-410X, 9 p.Article

The theoretical impact and cost-effectiveness of vaccines that protect against sexually transmitted infections and diseaseGARNETT, Geoff P.Vaccine. 2014, Vol 32, Num 14, pp 1536-1542, issn 0264-410X, 7 p.Article

Current status and prospects for development of a vaccine against Trichomonas vaginalis infectionsSMITH, Jeffrey; GARBER, Gary E.Vaccine. 2014, Vol 32, Num 14, pp 1588-1594, issn 0264-410X, 7 p.Article

Summary and recommendations from a National Institute of Allergy and Infectious Diseases (NIAID) workshop on Next Generation Herpes Simplex Virus VaccinesKNIPE, David M; COREY, Lawrence; COHEN, Jeffrey I et al.Vaccine. 2014, Vol 32, Num 14, pp 1561-1562, issn 0264-410X, 2 p.Article

Microbiome, sex hormones, and immune responses in the reproductive tract: Challenges for vaccine development against sexually transmitted infectionsBROTMAN, Rebecca M; RAVEL, Jacques; BAVOIL, Patrik M et al.Vaccine. 2014, Vol 32, Num 14, pp 1543-1552, issn 0264-410X, 10 p.Article

Current barriers, challenges and opportunities for the development of effective STI vaccines: Point of view of vaccine producers, biotech companies and funding agenciesDODET, Betty.Vaccine. 2014, Vol 32, Num 14, pp 1624-1629, issn 0264-410X, 6 p.Article